Shannon Hubbard has complex regional pain syndrome and considers herself lucky that her doctor hasn't cut back her pain prescription dosage. (Will Stone/KJZZ)
More than two dozen states nationwide that have developed guidelines for prescribing prescription pain pills. In Oregon, two task forces are looking at tightening prescribing guidelines for acute and chronic pain patients to try to stem overdoses.
When critics attacked Purdue Pharma for deaths linked to OxyContin, rivals stepped up their marketing of other potentially dangerous painkillers, such as fentanyl and morphine.
The number of overdose deaths have declined in Oregon, bucking the national trend. Prescription opioid use is down a quarter since 2013, and the number of queries to the Prescription Drug Monitoring Program have increased.
The public board that guides Oregon Health Authority policy is making progress on multiple fronts, but may need action from the Legislature to meet the state’s healthcare goals.
A separate bill to require health insurers to be more transparent about costs and formularies for consumers did not pass. Drugmakers, who helped spur the opioid crisis, are now profiting off the epidemic by jacking up the price of overdose treatment Naloxone.